NCT03678883 2026-04-03
9-ING-41 in Patients With Advanced Cancers
Actuate Therapeutics Inc.
Phase 2 Active not recruiting
Actuate Therapeutics Inc.
QuantumLeap Healthcare Collaborative
SN BioScience
National University Hospital, Singapore
Jiangsu Hansoh Pharmaceutical Co., Ltd.